A Clinicopathologic Study of Nineteen True Mesothelial Neoplasms, Other Than Adenomatoid Tumors, Multicystic Mesotheliomas, and Localized Fibrous Tumors

Publisher Website
Google Scholar
Abstract
Peritoneal mesotheliomas are rare in women, compared to serous epithelial neoplasms with which they are often confused. We evaluated the clinicopathologic features of 19 true mesothelial neoplasms affecting the genital tract or peritoneum of women (other than adenomatoid tumos, benign multicystic mesotheliomas, and localized fibrous tumors) to characterize their clinicopathologic features and to determine their clinical behavior. Six tumors were localized to one anatomic site at presentation, and 13 involved more than one anatomic site. The six localized tumors were solitary, small (0.8–2.0 cm), polypoid or nodular lesions, five of which were incidental findings. All had a predominantly tubulopapillary pattern, either pure or mixed with adenomatoid-like or small solid foci. Nuclear grade ranged from 0 to 2. Mitotic figures (MF) were absent in two tumors. The mitosis count in the other four tumors was < 1 MF/10 high-power microscopic fields (HPE) (average method) and ranged from 1 to 3 MF/10 HPF (highest count method). Five patients were alive without recurrence after postoperative intervals ranging from 19 months to 9 years (median. 5 years): one patient died of metastatic gastric carcinoma at 14 months. Thirteen tumors involved more than one anatomic site and were classified as diffuse mesothelioma. Typically, these tumors were symptomatic and accompanied by ascites. The tumors had either a plaque-like or endophytic configuration. Eleven were purely epithelial mesotheliomas, and two had a minor sarcomatoid component. Tubulopapillary patterns were present in 10 tumors, usually admixed with focal adenomatoid-like or solid patterns, and three had a purely solid pattern. All 13 tumors had grade 3 nuclei. The mitosis count ranged from < 1 to 2 MF/10 HPF (average count method) with a range of 1–4 MF/10 HPF by the highest count method. Immunohisto-chemically, 13/13 tumors stained for cytokeratin (AE1/AE3). None were immunoreactive for polyclonal carcinoembryonic antigen (CEA). Leu-M1, or B72.3. One diffuse mesothelioma stained focally for Ber-EP4, and electron microscopy confirmed the mesothelial nature of this tumor. Nine patients died of tumor after postoperative intervals ranging from 1 month to 6 years. Eleven patients had received postoperative adjuvant intraperitoneal or systemic chemotherapy. One patient died with increased abdominal girth 8 years after operation and one course of intraperitoneal chemotherapy, though the role of mesothelioma in her death was uncertain. One patient was alive with diffuse tumor and persistent ascites 25 months after six courses of intraperitoneal chemotherapy. One patient was alive without evidence of disease 4 months after two courses of systemic chemotherapy. One patient developed a recurrence 4 years following resection and six courses of intraperitoneal chemotherapy but was subsequently lost to follow-up. We conclude that (a) mesotheliomas affecting the genital tract and peritoneum in women, although rare, can be reliably distinguished from serous epithelial tumors: (b) clinically benign mesotheliomas are typically asymptomatic, incidentally discovered solitary tumors which are polypoid or nodular, small (2.0 cm or less), purely of epithelial type, with a predominant tubulopapillary pattern and generally low-grade nuclei: (c) clinically malignant mesotheliomas typically are symptomatic lesions which involve multiple sites, are associated with ascites, and have high-grade nuclei, though some tumors have foci with histologic features which overlap with clinically benign tumors.

This publication has 0 references indexed in Scilit: